Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.

Maura MassiminoMarie Pierre SunyachFrancesco BarrettaLorenza GandolaAnna GaregnaniEmilia PecoriFilippo SpreaficoAlice Bonneville-LevardDavid MeyronetCarmine MottoleseLuna BoschettiVeronica BiassoniElisabetta SchiavelloCarlo GiussaniGiorgio CarrabbaBarbara DilettoFederica PallottiRoberto StefiniAndrea FerrariMonica TerenzianiMichela CasanovaRoberto LukschCristina MeazzaMarta PoddaStefano ChiaravalliNadia PumaLuca BergamaschiCarlo MorosiGiuseppina CalaresoFelice GiangasperoManila AntonelliFrancesca Romana ButtarelliDidier Frappaz

Published in: Journal of neuro-oncology (2020)

The results obtained in our combined series are comparable with, or even better than those obtained after high CSI doses, underscoring the need to reconsider this treatment in adults.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
young adults
radiation therapy
patient reported outcomes
radiation induced